Production (Stage)
Alto Neuroscience, Inc.
ANRO
$3.03
$0.103.41%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -7.99% | 6.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.77% | -10.00% | |||
| Operating Income | 7.77% | 10.00% | |||
| Income Before Tax | 0.21% | 9.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.21% | 9.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.21% | 9.43% | |||
| EBIT | 7.77% | 10.00% | |||
| EBITDA | 7.86% | 10.32% | |||
| EPS Basic | 1.23% | 8.79% | |||
| Normalized Basic EPS | 5.64% | 8.82% | |||
| EPS Diluted | 1.23% | 8.79% | |||
| Normalized Diluted EPS | 5.64% | 8.82% | |||
| Average Basic Shares Outstanding | 1.03% | -0.69% | |||
| Average Diluted Shares Outstanding | 1.03% | -0.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||